Pacira BioSciences (PCRX) Non Operating Income (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Non Operating Income of -$1.9 million for Q1 2026, down 128.35% year-over-year from $6.7 million in Q1 2025, and down 7.63% quarter-over-quarter from -$1.8 million in Q4 2025.
Pacira BioSciences (PCRX) Non Operating Income (2010 - 2026) Analysis & Trends
Pacira BioSciences' Non Operating Income history runs 17 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 128.35% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$10.9 million (down 166.07% YoY), while the FY2025 annual figure was -$2.3 million, down 122.57% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1.9 million, down from -$1.8 million in the prior quarter.
- The five-year high for Non Operating Income was $8.3 million in Q2 2024, with the low at -$23.4 million in Q1 2023.
- The 5-year median for Non Operating Income is -$1.8 million (2025), against an average of -$3.9 million.
- Peak annual rise in Non Operating Income reached 1469.16% in 2025, while the deepest fall reached 315.21% in 2025.
- Pacira BioSciences' Non Operating Income stood at -$8.2 million in 2022, then jumped by 106.75% to $552000.0 in 2023, then jumped by 48.91% to $822000.0 in 2024, then sank by 315.21% to -$1.8 million in 2025, then slipped by 7.63% to -$1.9 million in 2026.
- Business Quant data shows PCRX's Non Operating Income at -$1.9 million in Q1 2026, -$1.8 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Pacira BioSciences | 946.10 Mn | 695.07 Mn | 148.24 Mn | -1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.71 Mn |
| Mar 31, 2026 | -1.90 Mn |
| Dec 31, 2025 | -1.77 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | 6.72 Mn |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 671,000.00 |
| Jun 30, 2024 | 8.34 Mn |
| Mar 31, 2024 | 428,000.00 |
| Dec 31, 2023 | 552,000.00 |
| Sep 30, 2023 | -1.12 Mn |
| Jun 30, 2023 | -2.02 Mn |
| Mar 31, 2023 | -23.38 Mn |
| Dec 31, 2022 | -8.18 Mn |
| Sep 30, 2022 | -19.22 Mn |
| Jun 30, 2022 | -9.23 Mn |
| Mar 31, 2022 | -10.10 Mn |
| Dec 31, 2021 | -10.41 Mn |
| Sep 30, 2021 | -7.20 Mn |